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Abstract Rationale: Long-term users of ecstasy have
shown impaired performance on a multitude of cognitive
abilities (most notably memory, attention, executive
function). Research into the pattern of MDMA effects
on executive functions remains fragmented, however.
Objectives: To determine more systematically what as-
pects of executive function are affected by a history of
MDMA use, by using a model that divides executive
functions into cognitive flexibility, information updating
and monitoring, and inhibition of pre-potent responses.
Methods: MDMA users and controls who abstained from
ecstasy and other substances for at least 2 weeks were
tested with a computerized cognitive test battery to assess
their abilities on tasks that measure the three submodal-
ities of executive function, and their combined contribu-
tion on two more complex executive tasks. Because of
sex-differential effects of MDMA reported in the litera-
ture, data from males and females were analyzed sepa-
rately. Results: Male MDMA users performed signifi-
cantly worse on the tasks that tap on cognitive flexibility
and on the combined executive function tasks; no
differences were found on the other cognitive tasks.
Female users showed no impairments on any of the tasks.
Conclusions: The present data suggest that a history of
MDMA use selectively impairs executive function. In
male users, cognitive flexibility was impaired and in-
creased perseverative behavior was observed. The inabil-
ity to adjust behavior rapidly and flexibly may have
repercussions for daily life activities.
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Introduction
Neurocognitive effects of MDMA
3,4-Methylenedioxymethamphetamine (MDMA, “ecsta-
sy”) appears to be a potent neurotoxin in rats (Mokler et
al. 1987), dogs (Frith et al. 1987), and non-human
primates (Ricaurte and McCann 1992). MDMA is toxic to
the serotonin (5-HT) system (Battaglia et al. 1988; Pan
and Wang 1990), and, to a lesser extent, to the dopamine
(DA) system (O’Shea et al. 2001). This neurotoxic effect
presumably also occurs in humans (McCann et al. 1998).
Long-term use of MDMA reduces 5-HT metabolites such
as 5-HIAA (McCann et al. 1994), neuroendocrine func-
tioning (Gerra et al. 2000), and the number of serotonin
re-uptake transporters (McCann et al. 1998). Moreover,
histological evidence shows that in MDMA-treated ani-
mals, 5-HT axon terminals are damaged and degenerated
(Commins et al. 1986).
In animals, MDMA reduces 5-HT in the medial
prefrontal cortex (Pan and Wang 1990), confirming the
5-HT depleting properties of MDMA (Schmidt et al. 1986;
Gibb et al. 1987; Mokler et al. 1987). In human volunteers,
a history of heavy MDMA use reduced 5-HT transporter
binding in the frontal cortex, striatal regions, and hypo-
thalamus (McCann et al. 1998). Studies in cognitive
neuroscience indicate that the frontal serotonergic system
is crucial in controlling learning and memory processes
(e.g. Hunter 1989; Epstein et al. 2002) and in behavior
involving high cognitive demands (Buhot 1997). Not
surprisingly, long-term MDMA use impairs performance
in several cognitive domains such as complex attention
(McCann et al. 1999; Gouzoulis-Mayfrank et al. 2000),
verbal memory (Morgan 1999; Fox et al. 2001a), visual
memory (Bolla et al. 1998), and retrospective (but not
prospective) memory (Zakzanis and Young 2001a).
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Effects of MDMA on executive functions
Executive functions can be described as general-purpose
control mechanisms that modulate the operation of
various cognitive subprocesses and thereby regulate the
dynamics of human cognition (Miyake et al. 2000). In
comparison with the extensive study of neurotoxic effects
on serotonergic neurocognitive function, the effects on
DA-mediated executive functions (EF) of the human
frontal lobes have been explored less systematically.
However, reports have begun to highlight toxic effects of
MDMA on the DA system (O’Shea et al. 2001) and on
executive function in human MDMA users. For instance,
MDMA users scored lower on the Behavioral Assessment
of Dysexecutive Syndrome, a test designed to measure
mental organization, planning strategies, thinking ahead,
mental rule forming, and the estimation of temporal
activities (Zakzanis and Young 2001b). MDMA users
show increased impulsivity (Morgan 1998), working
memory (WM) impairments (e.g. Bolla et al. 1998;
Wareing et al. 2000; Verkes et al. 2001), and impaired
performance on cognitive flexibility tasks (Fox et al.
2001b, 2002) and planning tasks (Fox et al. 2001b).
Thus far, however, the pattern of MDMA effects on EF
remains fragmented. Miyake et al. (2000) introduced a
differentiated theoretical framework for the systematic
study of EF. From their reading of the EF literature
Miyake and colleagues derived three core functions:
shifting between tasks and mental sets, updating and
monitoring of WM representations, and inhibition of
dominant or pre-potent responses. They assembled a
battery of tasks that included relatively simple tasks
(considered to differentially tap each of the core func-
tions) as well as a set of frequently used complex EF tasks
such as the Wisconsin Card Sorting Task and the Tower
of Hanoi. The results of this study indicated that, although
the core functions are moderately correlated with one
another, they are clearly separable. Moreover, structural
equations modeling suggested that the three functions
contribute differentially to the performance on the com-
plex EF tasks.
Based on Miyake et al.’s (2000) model, here we use a
broad range of EF tasks to clarify the possible influences
of MDMA on the executive processes. The first category
of EF is cognitive flexibility. Chronic amphetamine users
perform worse on extra-dimensional shift tasks (Ornstein
et al. 2000). Research in MDMA (a ring-substituted
amphetamine) users induced fewer errors on a similar task
(Fox et al. 2002). The second category of EF is working
memory updating and maintenance. Impairments of WM
have been found in MDMA users (Bolla et al. 1998;
Wareing et al. 2000; Verkes et al. 2001). The third
category of EF is response inhibition. Increased impul-
sivity has been indicated in MDMA users (Morgan 1998).
However, on a go/no-go inhibition task, MDMA users
performed equally well as controls (Fox et al. 2002). Tests
assessing each of the three components of EF were
administered, together with more complex EF tasks to
explore situations that place higher cognitive demands on
multiple types of EF simultaneously. Previous research
has shown MDMA users to make more perseverative
errors on more complex EF task such as the Wisconsin
Card Sorting Test (WCST) and to use increased planning
times on the Tower of London (TOL) (Fox et al. 2001b).
Several psychiatric and/or psychobiological problems
are associated with MDMA usage. These include sleep
disorders, depressed mood, persistent high anxiety, and
impulsiveness and hostility (Morgan 2000). In previous
research, MDMA users scored higher on several dimen-
sions of the Symptom Check List 90 (SCL-90): paranoid
ideation, psychoticism, summarization, obsessionality,
anxiety, hostility, phobic anxiety, altered appetite, restless
sleep, and greater impulsiveness (Parrot et al. 2000).
Dughiero et al. (2001) also reported higher scores by
MDMA users on several scales of the SCL-90: obsession-
compulsion, phobic anxiety, psychoticism, and sleep
disturbances. In order to obtain a clear perspective of
the effects of MDMA on psychological distress, we
therefore administered the SCL-90 clinical symptom self-
rating scale.
We also distinguished between male and female
MDMA users because of the different findings for the
two sexes. McCann et al. (1994) reported increased
reductions in the 5-HT metabolite 5-HIAA in female
users. Liechti et al. (2001) found a stronger subjective
response in female users compared to male users. Reneman
et al. (2001) reported a stronger dose-dependent reduction
in 5-HT binding ratios in female than in male MDMA
users. Finally, Verheyden et al. (2002) reported higher
depression scores in females several days following
weekend use of MDMA. In this study, both men and
women reported increased self-rated aggression.
The present study contributes to the literature a more
detailed and systematic analysis of the effects of MDMA
on EF. The selected cognitive test battery was designed to
tap into each of the three lower-order categories sepa-
rately and their combined contribution to performance on
more demanding cognitive tasks. This approach enables
us to study more systematically the neurotoxic effects of
MDMA on cognitive flexibility, working memory updat-
ing and maintenance, and response inhibition, in simple
and complex cognitive tasks.
Materials and methods
Participants
Fifty-nine participants (29 males, 30 females) were recruited, of
whom 26 were MDMA users and 33 were not. Participants were
first-year psychology students who received study credits for
participation. All were between 18 and 26 years of age, otherwise
healthy, and without psychiatric history according to self-report. In
order to participate in the MDMA group, a total minimum
consumption of ten ecstasy tablets was required with at least one
occasion in the most recent year. Because all participants were
university students, comparable intelligence levels were assumed.
Participants agreed to abstain from use of all psychoactive drugs for
at least 2 weeks before the study. Compliance with this instruction
was stimulated by the announcement that saliva samples would be
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taken. At the beginning of the testing session, all participants were
interviewed on drug use within the last 2 weeks, pregnancy, and
medical or psychiatric illness. Written informed consent was
obtained from all participants, and the nature and possible
consequences of the study were explained to them. Experimental
procedures were conducted in compliance with relevant laws and
institutional guidelines, and were approved by the local depart-
mental ethical committee.
Cognitive performance
The tasks used in this experiment were from a task battery
developed by Huizinga and van der Molen (unpublished data).
They adopted the approach described in the study reported by
Miyake et al. (2000), and examined developmental patterns in the
following executive functions: (1) updating and monitoring of WM
representations, (2) shifting between tasks and mental sets, and (3)
inhibition of dominant or pre-potent responses. The tasks have been
validated and found reliable in the literature (as indicated below) or
were developed by adopting appropriate analogues of existing
paradigms (Huizinga and van der Molen, unpublished data).
In the present study, the battery consisted of eight tasks: two
task switching paradigms (Dots-Triangles and Local-Global), two
WM tasks [Tic Tac Toe (visual information) and Mental Counters
(numerical information)], two response inhibition tasks (Eriksen
Flankers and Stop Signal) and two complex EF tasks (WCST and
TOL).
Flexibility
Dots-Triangles
The Dots-Triangles test (derived from Miyake et al. 2000) involves
the maintenance and switching of response set. In a 44 grid on the
screen, varying numbers of either dots or triangles appear. With
dots, participants have to decide whether there are more dots in the
left or in the right part of the screen (block 1; 30 practice trials, 50
experimental trials). With triangles, participants have to decide
whether there are more triangles in the top or in the bottom part of
the screen (block 2; 30 practice trials, 50 experimental trials).
Blocks 1 and 2 were administered in randomized order. In a third
block (90 practice trials, 150 experimental trials), participants
alternated between series of four “dots” trials and series of four
“triangles” trials. A stimulus remained on the screen until a
response was made; the maximum RT was 3500 ms, the interval
between the response and a new stimulus was 1000 ms.
Local-Global
The Local-Global test (derived from Miyake et al. 2000) requires
participants to respond to randomly presented rectangles or squares
by pressing a left or right response button, respectively. Larger
(global) rectangles/squares consist of smaller (local) rectangles or
squares. Participants respond only to the local figure, or only to the
global figure (blocks 1 and 2, in randomized order; 30 practice trial
and 50 experimental trials per block), in the third block, they had to
alternate between series of four “local” trials and series of four
“global” trials (block 3; 90 practice trials, 150 experimental trials).
A cue instructed participants as to which aspect (global or local)
should be responsed to; the stimulus remained on the screen until a
response was made, the maximum RT was 3500 ms, the interval
between the presentation of the cue and the presentation of the
stimulus was 500 ms, the interval between the response and the
presentation of the new cue was fixed at 1000 ms.
Working memory
The essence of this function lies in the requirement to monitor and
code incoming information for relevance and replace information
held in WM that is no longer relevant by new, relevant information.
Two tasks are chosen that are assumed to tap this updating function,
differing in the information that needs to be updated as well as in
the goals of the tasks.
Tic Tac Toe
In the Tic Tac Toe test (modified from Milner 1971), participants
are required to keep visual information active in WM about the
orientation of a pattern of figures. In a 33 grid on the screen, Xs
and Os are presented briefly during a memorizing phase. In the
recognition phase, Xs and Os are presented one after another in the
grid. The task is to press a button as soon as the combination of
presented Xs and Os matches the pre-specified pattern. Memory
load is varied using patterns consisting of three or four stimuli. The
number of trials per block was 15, and the series length of the
stimulus presentation until the pre-specified pattern was reached
varied from four to nine presentations. The maximum RT was
3500 ms, the interval between the presentation of stimuli was
between 900 and 1100 ms (randomly drawn from a uniform
distribution).
Mental Counters
The Mental Counters test (adapted from Larson et al. 1998)
requires participants to keep numerical information active in WM.
Participants must keep track of the values of two or three (blocked)
independent “counters” which change rapidly and in random order.
The counters consist of a horizontal line, above or below which
squares appear.
Participants were to add 1 to the value of the counter when a
square appeared above the line, and to subtract 1 when it appeared
below the line. When any counter reaches a given criterion value,
participants have to press a button. The length of the series of
stimuli presented was five or seven (randomly but equiprobably);
the maximum RT was 3500 ms, the interval between consecutive
presentations of squares was between 1000 and 1300 ms (randomly
drawn from a uniform distribution).
Response inhibition
Eriksen Flankers
In the arrow version of the Eriksen Flankers test (Ridderinkhof and
van der Molen 1995), the participant’s task is to respond to a left
versus right pointing arrow in the center of the screen by pressing a
left or right response button. The central arrow is flanked by four
arrows pointing in the same direction (congruent condition).
Occasionally and unpredictably, the flankers will point in the
opposite direction (incongruent condition), thereby activating the
competing response. The stimulus was presented in a rectangle, and
this rectangle served as the warning stimulus, that is, after an
interval of 500 ms the target stimulus appeared in the rectangle. The
stimulus remained on the screen until a response was made; the
maximum RT was 3500 ms, the interval between the response and
the presentation of the warning stimulus was fixed at 1000 ms.
There were 50 practice trials, and 100 experimental trials.
Stop Signal Task
In this version of the Stop Signal task (Van Boxtel et al. 2001),
participants have to respond as fast as possible to a left versus right
pointing arrow by issuing a left versus right button press.
Occasionally and unpredictably (on 25% of all trials), the color
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of the arrow changes from green to red indicating that the response
should be inhibited. The time interval between arrow presentation
and arrow color change ranges from 200 to 1250 ms: the longer it
takes the arrow to change color, the more difficult it is to stop the
pre-potent response. The length of this interval is controlled by a
tracking algorithm through which stop accuracy approximates 50%.
There were 50 practice trials, and two blocks of 100 experimental
trials. The stimulus remained on the screen until a response was
made; the maximum RT was set at 1250 ms, the interval between
the response and the new stimulus varied between 1650 and
2150 ms (drawn randomly from a uniform distribution).
Complex executive functions
Tower of London (TOL)
The TOL (Shallice 1982; Schnirman et al. 1998) requires the
movement of three different-colored balls across three different-
sized pegs in order to duplicate the goal configuration. The smallest
peg can hold one ball, the middle-sized two, and the largest can
hold three balls. Only the highest ball on a peg can be moved and
only one ball can be moved at the same time. Several trial types
have to be completed: 4-move trials, 5-move trials, and 6-move
trials. Trials are scored for planning time and solution time.
Participants’ performance is also scored for percentage of excess
moves, and total number of moves needed to complete the
configuration.
Wisconsin Card Sorting Task (WCST)
The WCST (Grant and Berg 1948; Heaton et al. 1993) requires the
deduction of correct sorting rules and the flexible execution of
these rules. This task engages WM operations as well as switch
capacities and inhibitory control. Four stimulus cards with figures
appear on the screen. These figures vary along three dimensions:
number (1–4), color (red, green, yellow, blue), and form (triangles,
stars, crosses, circles). A response card, which matches the stimulus
cards on one or two dimensions, is presented on the bottom of the
screen. Participants have to respond with a button press (keys 1, 2,
3, or 4) to select the stimulus card that matches the response card
best according to one of the three sorting dimensions. The sorting
dimension is changed after ten correct responses, and participants
have to figure out the new sorting dimension in order to respond
successfully. Participants’ performance was scored for the number
of conceptual level responses (series of three or more consecutive
correct responses), the total number of correct responses, the
number of correct responses on ambiguous trials, the number of
errors on ambiguous trials, and, most importantly, the number of
perseverative errors (trials following a switch of sorting dimension,
on which participants persist in sorting according to the preceding
sorting dimension that is now incorrect).
Symptom Checklist-90 (SCL-90)
A Dutch computerized version of the SCL-90 self-rating scale
(Derogatis 1994) was administered at the end of the testing session.
The test consists of 90 symptoms, which are divided into several
psychiatric and psychobiological dimensions: depression, anxiety,
agoraphobia, insufficiency of thought and behavior, sensitivity,
somatization, hostility, and sleeping problems. The SCL-90 was
used because all nine dimensions are strongly associated with 5-HT
regulation. Example questions are: “feelings of worthlessness”
(depression subscale) and “feeling easily annoyed and irritated”
(hostility subscale). Each question has five possible responses,
ranging from not at all (1) to extremely (5). The response is to be
based on the last 4 weeks. Dependent measures are the sum scores
on each dimension and the total SCL-90 score (i.e. the sum of
all nine subscale sum scores; minimum score=50, maximum
score=450).
Statistical analyses
Homogeneity differences between the four groups were investigat-
ed by c2 analysis. Independent samples t-tests were performed for
analysis of age differences between MDMA users and controls, and
between sexes. Sex differences in MDMA use were analyzed by
one-way analysis of variance (ANOVA). Differences between
groups in cognitive task measures were analyzed using ANOVA
with MDMA usage and sex as between-subjects independent
variables. Within the MDMA group, a median split was performed
to discriminate between high and low use of other drugs, and to
control for the variance in XTC-related performance impairments
accounted for by the concomitant use of these other drugs (using
ANOVA). Independent samples t-tests were performed on the SCL-
90 scores of MDMA users and controls. An alpha level of 0.05 was
used for all analyses.
Results
Demographics and drug-usage data
Demographics of the participants are provided in Table 1.
The c2 analysis indicated a non-homogeneous composi-
tion of the groups [c2(59)=4.901, P=0.03]. There were no
Table 1 Demographics, SCL-90 scores, and use of other recreational drugs
Men controls (n=12) Men MDMA (n=17) p Women controls (n=21) Women MDMA (n=9) P-value
Demographics
Age (years) 22.0 (2.0) 21.4 (1.3) 21.4 (2.2) 21.7 (1.3)
SCL-90 104.33 (7.25) 121.82 (24.64) b 117.33 (21.32) 120 (12.52)
Other recreational drug usea
Cannabis 0.54 (1.42) 10.59 (12.07) b 0.07 (0.18) 3.89 (8.08) b
Amphetamine 0 4.35 (8.75) 0 2.78 (5.26) b
LSD 0 0.88 (1.73) 0 0.22 (0.44) b
Psilocybin 0.08 (0.29) 2.82 (2.65) b 0 3.00 (2.96) c
Cocaine 0 6.88 (7.28) b 0 3.33 (4.03) c
GHB 0 0.35 (1.22) 0 4.11 (6.94) c
Sedatives 0.17 (0.56) 2.35 (6.64) 0.29 (1.1) 0
Herbal 0 11.35 (18.26) a 0 9.13 (10.68) c
a Total number of occasions that the drug was used, with the exception of cannabis: the number of cannabis joints per month
b Significant difference at a=0.05
c Significant difference at a=0.01
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age differences between the control and MDMA groups
[t(57)=0.23, P=0.82], either for men [t(27)=0.929 P=
0.36], or for women [t(28)=0.378, P=0.71]. Male
MDMA users consumed significantly more cannabis,
cocaine, psilocybin mushrooms, and herbal ecstasy than
the male controls. Female MDMA users consumed
significantly more of all other (non-MDMA) drugs than
the female controls, except for sedatives.
The average number of ecstasy tablets used by the
MDMA group was 46.30, SD 30.56 (Table 2). The
average frequency of ecstasy use was 1.70 tablets per
month, SD 2.08. The tendency that on average males used
higher quantities of MDMA than females was not
statistically reliable [F(1,24)=1.452, P=0.24].
Task data
The results per cognitive task are summarized below, and
can be seen in Table 3. Due to technical failure, for a few
participants’ data from some of the tasks were incom-
plete, hence sample sizes are indicated per task. Partic-
ipants were excluded from the analyses if their accuracy
was below 55% on relevant conditions. Results are
described for males and females separately.
Flexibility
Switch costs are defined as the decrease in response speed
or accuracy in task-alternations compared to task-repeti-
tion trials within mixed-task blocks. Mixing costs are
defined as the decrease in response speed or accuracy in
task-repetition trials in mixed-task blocks compared to
task-repetition trials within single-task (non-switch)
blocks. Mean reaction times (RTs) and accuracy (i.e.
the percentage correct) were submitted to a separate
repeated measures ANOVA with Switch trial type (rep-
etition versus switch) or Mixing trial type (repetitions in
single-task blocks versus repetitions in mixed blocks) as
within-subjects factor, and group (MDMA users versus
controls).
Dots-Triangles (n=57)
Switch costs; RT. Results showed that male MDMA users
responded more slowly [F(1,26)=9.634, P=0.01] than
controls, and in this group responses to switch trials were
significantly slower than to repetition trials [F(1,26)=
40.134, P<0.01]. Moreover, male MDMA users had
higher switch costs [F(1,26)=4.913, P=0.04] than con-
trols. In the female group, there was no main effect for
Group, but the main effect for Switch trial type was
significant [F(1,27)=42.632, P<0.01]. The GroupSwitch
trial type interaction failed to reach significance.
Switch costs; accuracy. Male MDMA users were more
accurate than controls [F(1,26)=5.049, P=0.03], and in
this group the Switch trial type effect was significant
[F(1,26)=16.579, P<0.01]. Male MDMA users, however,
did not differ in switch costs [F(1,26)=0.07, P=0.79] from
controls. In female users, there was no main effect for
Group, but the Switch trial type effect was significant
[F(1,27)=64.216, P<0.01]. Moreover, in this group switch
costs for MDMA users were larger compared to controls
[F(1,27)=5.360, P=0.03].
Mixing costs; RT and accuracy. In the male group, there
were only main effects of Group on RT and accuracy
[F(1,26)=6.094, P=0.02; and F(1,26)=6.064, P=0.04,
respectively]. Furthermore, the main effect of Mixing
trial type on accuracy was significant [F(1,26)=83.243,
P<0.01]. In the female group, no main effects were found
for Group, and the main effect for Mixing trial type was
significant only on RT [F(1,27)=70.437, P<0.01]. Mixing
costs on RT and accuracy did not differ between MDMA
users and controls.
Local-Global (n=57)
Switch costs; RT. Compared to controls, male MDMA
users were slower than controls [F(1,27)=5.178, P=0.03],
and a main effect of Switch trial type was found [F(1,27)=
37.023, P<0.01]. Moreover, male MDMA users showed
higher switch costs [F(1,27)=8.705, P=0.01]. Within the
female group there were no significant MDMA differ-
ences for RT latency, although the main effect of Switch
trial type was significant [F(1,26)=18.924, P<0.01].
Moreover, the GroupSwitch trial type interaction failed
to reach significance.
Switch costs; accuracy. In both the male and female
groups, the main effects and the interaction between the
factors failed to reach significance.
Mixing costs; RT and accuracy. In the male group, there
was only a main effect of group [F(1,27)=5.071, P=0.03]
on accuracy. In the female group, there was only a main
effect for Mixing trial type [F(1,26)=11.912, P<0.01].
Table 2 Characteristics of ec-
stasy use
MDMA (n=26) Men (n=17) Women (n=9)
Total cumulative number of ecstasy tablets 53.82 (35.56), range: 10–120 38.78 (14.95), range: 14–60
Frequency of ecstasy usea 1.96 (2.44), range: 0.25–10 1.44 (1.20), range: 0.25–4
Duration of use in years 2.28 2.24
a Number of ecstasy tablets per month.
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Working memory
Tic Tac Toe (n=56)
Mean RTs and accuracy (i.e. the percentage correct) were
submitted to a separate repeated measures ANOVA with
WM load (low versus high) as within-subjects factor, and
Group (MDMA users versus controls) as between-sub-
jects factor. The only significant finding for RT was a
cross-over interaction between WM-load and MDMA use
in males [F(1,24)=5.115, P=0.03]. This interaction re-
flects the pattern that male MDMA users responded more
slowly in when WM load increased, whereas controls
were in fact faster under the higher WM load. In the
female group, all effects failed to reach significance.
There were no significant effects on accuracy in either the
male or the female group.
Mental Counters
Due to data storage failure, only 47 participants success-
fully completed this task. Mean RTs and accuracy were
submitted to separate repeated measures ANOVA with
WM load (low versus high) and series length (short versus
long) as within-subjects factors, and Group (MDMA users
Table 3 Means and standard deviations of all relevant measures on all tasks and SCL-90 scores for men and women
Costs and effects Men p Women p
Controls MDMA Controls MDMA
Flexibility
Dots-Triangles RT (ms) 697.8 (62.2) 910.38 (50.1) b 826.69 (46.2) 938.64 (68.9)
% Correct 89.2 (2.5) 94.9 (2.0) a 86.0 (1.8) 92.3 (2.7)
Switch Cost (ms) 134.7 279.6 a 200.7 274.80
Switch Cost (%) 3.8 4.3 4.8 8.7 a
Mixing Cost (ms) 169.4 243.7 195.4 226.4
Mixing Cost (%) 4.1 1.5 6.0 1.3
Local-Global RT (ms) 412.1 (17.9) 459.2 (15.0) a 457.2 (13.9) 440.3 (21.9)
% Correct 95.3 (0.7) 97.0 (0.6) 96.2 (0.6) 97.1 (0.9)
Switch Cost (ms) 17.6 50.7 b 59.8 36.8
Switch Cost (%) 0.2 0.7 0.1 0.1
Mixing Cost (ms) 21.7 0.6 22.0 24.2
Mixing Cost (%) 0.7 0.5 0.6 0.0
WM
Tic Tac Toe RT (ms) 376.6 (17.4) 385.6 (16.1) 379.1 (13.1) 376.8 (20.0)
Load effect 23.9 19.2 a 25.5 16.1
% Correct 94.9 (2.4) 91.1 (2.2) 93.0 (1.8) 93.0 (2.7)
Load effect 1.4 5.6 3.0 1.9
Mental Counters RT (ms) 413.6 (44.1) 586.2 (34.2) a 540.3 (33.1) 544.7 (50.0)
% Correct 92.9 (1.6) 89.6 (1.2) 89.7 (1.2) 89.7 (1.8)
Inhibition
Eriksen Flankers RT (ms) 414.6 (15.4) 445.6 (12.4) 437.6 (9.3) 417.8 (14.0)
Interf. Cost (ms) 53.5 50.1 44.9 51.7
% Correct 96.7 (1.5) 96.6 (1.2) 96.7 (0.6) 99.3 (0.9) a
Interf. Cost (%) 6.2 5.9 5.8 0.8 a
Stop signal SSRT (ms) 204.9 (62.6) 195.2 (39.0) 202.8 (68.4) 236.8 (91.9)
Complex EF
TOL % Excess moves 31.7 (4.4) 54.1 (3.7) b 55.2 (3.3) 55.6 (5.1)
Total moves 27.3 (1.5) 31.9 (1.3) b 33.1 (1.2) 34.7 (1.8)
Planning time (s) 14.5 (2.0) 7.7 (1.7) b 10.1 (1.5) 8.8 (2.3)
Total time (s) 30.7 (2.5) 26.5 (2.1) 33.4 (1.9) 33.5 (2.8)
WCST Total no. correct 77.1 (3.1) 70.8 (2.6) 69.2 (2.3) 75.7 (3.6)
No.correct ambig. 1.5 (0.6) 3.2 (0.5) 2.0 (0.5) 1.6 (0.7)
No. persever. error 11.3 (2.6) 18.8 (2.2) a 14.4 (2.0) 14.4 (3.0)
No. ambig. error 10.2 (2.0) 15.8 (1.6) a 12.2 (1.5) 12.8 (2.2)
Conceptual level 70.8 (3.7) 59.5 (3.1) a 62.2 (2.8) 67.0 (4.3)
SCL-90
Anxiety 10.6 (0.9) 13.2 (3.2) b 13.8 (3.2) 13.7 (1.6)
Agoraphobia 7.2 (0.4) 8.1 (2.6) 7.9 (1.7) 7.6 (1.0)
Depression 18.8 (2.3) 21.1 (5.5) 21.9 (5.4) 21.9 (3.1)
Somatization 15.2 (2.0) 16.2 (3.9) 15.9 (3.8) 16.4 (3.0)
Insufficiency 11.7 (1.2) 15.9 (4.5) a 13.3 (3.7) 15.3 (4.5)
Sensitivity 20.8 (2.2) 25.2 (6.1) a 22.4 (4.5) 23.1 (2.8)
Hostility 7.0 (1.3) 7.6 (2.1) 6.8 (1.1) 7.0 (1.0)
Sleeping problem 3.5 (0.7) 4.3 (1.9) 4.9 (2.9) 4.1 (1.0)
Total SCL-90 104.3 (7.3) 121.8 (24.6) a 117.3 (21.3) 120 (12.5)
a Significant difference at a=0.05
b Significant difference at a=0.01
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versus controls) as between-subjects factor. Male MDMA
users were slower than controls [F(1,22)=7.141, P=0.01],
and there was a main effect for series length on RT
[F(1,22)=7.601, P=0.01]. The interactions failed to reach
significance. Within the female group, no significant
effects on RT were found. The only significant effect on
accuracy was for WM load [F(1,20)=6.365, P=0.02] in
the female group.
Inhibition
Eriksen Flankers (n=54)
Mean RTs and accuracy were submitted to a separate
repeated measures ANOVA with interference (congruent
versus incongruent) as a within-subjects factor and Group
(MDMA users versus controls) as a between-subjects
factor. An interference effect on RT was observed for
males [F(1,26)=139.168, P<0.01] and females [F(1,24)=
228.794, P<0.01], indicating that responses to incongruent
stimuli were slower than to congruent stimuli. This effect
did not differ between MDMA groups. For accuracy, an
interference effect was also observed for males [F(1,26)=
9.935, P<0.01] as well as females [F(1,24)=9.167, P=0.01].
In the female group, there was also a significant effect of
Group [F(1,24)=5.773, P=0.02] and a GroupInterference
interaction effect [F(1,24)=5.362, P=0.02]. This indicates
that accuracy in females with a history of MDMA use was
impaired in incongruent (compared to congruent) condi-
tions more than in their controls.
Stop Signal (n=57)
The dependent variable in the Stop Signal task was the
stop-signal RT (SS-RT) an index of the efficiency of
response inhibition. The data of five MDMA users (two
females) and of nine controls (six females) were excluded
because they failed to inhibit on more than 85% of the
trials. Male and female MDMA users did not differ
significantly on SS-RTs. An additional analysis was
conducted to establish whether the speed of stopping was
distinct from go-RT. Analysis of covariance (ANCOVA)
on simple SS-RT, entering go-RT as a covariate, yielded a
no significant main effect of SS-RT.
Complex tasks
Tower of London (n=59)
Four dependent variables (i.e. the number of extra moves,
the number of total moves, planning time, and total time)
were submitted to univariate ANOVAs. Significant dif-
ferences between the male MDMA users and controls
were found on most dependent measures. Male users
needed more extra moves [F(1,27)=13.806, P<0.001], and
hence had more total moves [F(1,27)=8.101, P=0.01].
Compared to controls, male users needed less planning
time to make the initial response [F(1,27)=7.164,
P=0.01], and completed the configuration in less total
time, although the latter difference was not significant.
There were no significant differences between the female
users and their controls.
Wisconsin Card Sorting Task (n=59)
Six dependent variables (i.e. the number of correct
responses, the number of correct responses on ambiguous
trials, the number of perseverative errors, and conceptual
level responses) were submitted to univariate ANOVAs.
There were no significant group differences in the number
of correct responses on ambiguous trials or in the total
number of correct responses. Compared to controls, male
MDMA users made more perseverative errors [F(1,27)=
6.32, P=0.02], more errors on ambiguous trials [F(1,27)=
6.81, P=0.02], and had an impaired conceptual level
response [F(1,27)=6.41, P=0.02]. Within the female
group, there were no significant differences between the
users and controls.
Symptom Checklist-90 (SCL-90)
Male users scored higher on the overall SCL-90 score
[F(1,27)=16.21, P=0.03], on the subscales sensitivity
[F(1,27)=12.36, P=0.02], anxiety [F(1,27)=9.95, P=0.01]
and insufficiency of thought and behavior [F(1,27)=
12.40, P=0.02]. The amount of MDMA used correlated
significantly with the scores on the subscales insufficien-
cy of thought and behavior (r=0.308, P=0.018) and
sensitivity (r=0.293, P=0.024). Within the female partic-
ipant group, no significant differences were observed.
Post hoc analyses
To investigate the influence of polydrug use on our
findings, those analyses that were reported above to yield
significant effects of MDMA use were followed up by
additional analyses to examine whether task performance
within the MDMA user groups varied as a function of the
quantities of recreational consumption of other drugs.
These follow-up analyses featured an additional between-
subjects factor: high-cannabis versus low-cannabis use,
high-cocaine versus low-cocaine use, high-psilocybin
versus low-psilocybin mushroom use, or high-herbal
versus low-herbal ecstasy use (in separate ANOVAs).
High-use versus low-use on each of these drugs was
determined using a median split within the male and
female MDMA groups separately. None of these addi-
tional factors modulated the main or interaction effects
reported above, either in males or in females, except in
one isolated instance. Among male MDMA users, who
showed RT higher switch costs than controls in the Local-
Global task, these switch costs were greater in magnitude
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for high compared to low users of herbal ecstasy
[F(1,15)=5.13, P=0.039]. Possibly, the power of these
analyses was limited due to small sample size. As an
additional approach therefore, correlation coefficients
were calculated between total MDMA use and the total
amount of other drugs that were used within the MDMA
group. All correlation coefficients were low and non-
significant. Thus, both analytical approaches converged
on the conclusion that within the MDMA group the use of
other drugs had no measurable impact on the cognitive
scores, with the possible exception of a modulatory effect
of herbal ecstasy on cognitive flexibility.
Discussion
Thus far, the literature on neurocognitive effects of
MDMA consumption has emphasized 5-HT mediated
effects on memory. Reports of effects on (presumably
DA-mediated) executive functions also begin to emerge
but the patterns are still fragmentary. The framework of
Miyake et al. (2000) was used here for a more systematic
study of ecstasy effects on EFs, using an experimental test
battery designed to examine the EF categories of cogni-
tive flexibility, working memory updating, and inhibition
of pre-potent responses.
Consistent with previous findings, we observed selec-
tive cognitive impairments in recreational ecstasy users
(e.g. Bolla et al. 1998; Fox et al. 2001a). Considerable
impairments were observed in male users compared to
non-users on response speed and switch costs in set
shifting tasks, and on performance in the more complex
executive function tasks, as well as on the SCL-90 self-
rating scale. Thus, having a history of MDMA consump-
tion selectively impaired performance on complex EF
tasks and on one of its subcategories, set shifting, while
leaving the subcategories of working memory updating
and response inhibition relatively preserved. In female
participants, virtually no significant differences were
found between users and non-users.
Speeded performance in the task-switch paradigm was
affected by MDMA in the male user group. On both the
Dots-Triangles task and (to a lesser extent) the Local-
Global task, switch costs were higher in the user group,
indicating that mental set-switching abilities were im-
paired. Previously, Fox et al. (2002) reported only minor
effects of MDMA on attention switching, but consider-
able shortcomings in verbal memory. These authors
assumed that the detrimental effects of MDMA on EFs
are noticeable only after prolonged use, while verbal WM
abilities are affected already after shorter periods of
MDMA consumption. The present study, however, re-
vealed negative effects of MDMA on cognitive flexibility
using an apparently more sensitive measure, namely
switch costs in task switching.
In the present study, the effects of MDMA use on WM
tasks remained small and were much less pronounced
compared with the results of some other studies (e.g.
Wareing et al. 2000; Fox et al. 2001a, 2002; Verkes et al.
2001). The only effect in the present study was a cross-
over interaction between WM-load and MDMA use on
RT in the Tic Tac Toe task, with male users suffering
from higher WM loads while controls showed the
opposite pattern. One possible explanation for the dis-
crepancy between our findings and the more clear-cut
findings on WM tasks found elsewhere could relate to the
nature of the WM tasks used. While most previous studies
used verbal WM tasks, the WM demands in the present
study were more visual and numerical in nature. Verbal
WM capacities may be more sensitive to the effects of
MDMA, although visual WM impairments have also been
reported (Bolla et al. 1998). Another factor that may play
a role in the current lack of deterioration concerns the
precise WM operations engaged in the tasks: the present
tasks capitalized on information updating in WM, in-
volving primarily the central executive, whereas in
previous studies more emphasis may have been put on
the efficiency of storage and retrieval of relevant infor-
mation in WM stores. Possibly, memory-storage functions
are more susceptible to MDMA-induced decline than
memory updating functions.
Performance on inhibition tasks was hardly affected by
MDMA use in the present research. The Stop Signal task
and the Eriksen Flankers task both draw on the capability
to suppress responses that are inappropriately activated
(Ridderinkhof et al. 1999). In terms of both SS-RT and
flanker interference effects on RT, MDMA users and non-
users performed equally well. The only MDMA effect on
inhibition was observed in the Eriksen Flankers task,
where female MDMA users showed a stronger effect of
incongruence on accuracy than controls. Overall, these
findings are consistent with reports showing no differ-
ences between MDMA users and controls in performance
on a go/no-go task (Fox et al. 2002). Since all these
paradigms appear to be highly sensitive to individual
differences in the efficiency of response inhibition, the
conclusion seems warranted that inhibitory capacities
(presumably mediated by lateral prefrontal cortex) are
largely preserved in recreational ecstasy users.
Significant differences between male MDMA users
and controls were found on the complex EF tasks. In the
WCST, users performed worse on virtually all the
dependent measures. This finding is consistent with those
reported by Fox et al. (2001b), who also observed more
errors of perservation in MDMA users. Thus, the recre-
ational consumption of ecstasy results in deficiencies in
the adaptive ability to adjust behavior in response to
changing environmental demands. Fox et al. (2001b) also
observed group differences on TOL performance. In their
study, MDMA users needed longer planning times in the
TOL, whereas in our research, shorter planning times
were found. This difference may be explained by higher
impulsivity in MDMA users in the present sample, as also
reported in previous research (Morgan 1998). Because of
their impulsivity, MDMA users may commence the TOL
sooner, and spend less time on planning the steps to be
taken. As a result, planning times are shorter, but the
number of excess moves is higher.
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The MDMA-induced rises in perseverative behavior
on the WCST and in switch costs in task switching are
both linked to adaptive control. In studies of cognitive
development and aging, age-related increases in perse-
verative behavior in experimental analogues of the WCST
were found to be generated primarily by deficiencies in
the ability to shift set (Ridderinkhof et al. 2002b; Crone et
al. 2004). Similar to individual differences brought about
by age, those brought about by MDMA usage may also be
closely related to task switching abilities. Both persever-
ative behavior and switch costs emanate from failure to
shift set or to adjust a cognitive strategy in order to
successfully complete a new task. These adaptive control
failures are consistent with the results of studies on
differences between MDMA users and controls in their
performance on a multitude of executive tasks (Milani
and Schifano 2000; Wareing et al. 2000; Fox et al.
2001b). The considerable effects of MDMA on cognitive
flexibility (in switch tasks and the WCST) in the absence
of effects on WM updating and response inhibition
warrants the inference that sustained MDMA consump-
tion incurs a selective impairment on one category of EF
(as defined in the model Miyake et al. 2000), namely
cognitive flexibility.
It should be noted that all participants in the MDMA
group were recreational users with a mean consumption
of 1.7 XTC tablets per month. This form of drug use can
be described as moderate, with the users living generally
healthy, having a regular daily routine, and not suffering
from obvious adverse effects, either mentally or physi-
cally. The exposure to MDMA is at the lower end of the
range reported elsewhere in the literature (Bolla et al.
1998; Fox et al. 2001a). The present finding of mild
cognitive impairment in moderate users may implicate
more profound effects for users who consume MDMA
more frequently or have a more prolonged history of drug
use. Furthermore, clear disparities were observed between
males and females in the effects of MDMA on task
performance. Our choice to analyze the sexes separately
was motivated by several findings (e.g. McCann et al.
1994; Liechti et al. 2001; Reneman et al. 2001; Verhey-
den et al. 2002) in which long-term effects of MDMA
were more pronounced in females than in males. This
difference is typically explained by the lower average
body weight in females, which makes them potentially
more susceptible to the neurotoxic effects of MDMA. In
our research, however, differences in task performance
were found almost exclusively in the male user group. It
should be noted that the male users had a history of higher
MDMA consumption than females, measured as the
cumulative number of ecstasy tablets: on average 53.82
versus 38.78 tablets, respectively. Although this differ-
ence failed to obtain statistical significance, due presum-
ably to substantial within-group variability in MDMA
consumption, it may well have played a role in producing
the present sex differences.
A considerable number of our MDMA users were
polydrug users. These polydrug users had a history of
consumption of cannabis and cocaine in substantial
amounts, and of several other (non-MDMA) drugs in
more moderate quantities. Since cannabis and cocaine
have been reported to impair various aspects of cognitive
function (e.g. Schwartz et al. 1989; Mittenberg and Motta
1993; Rosselli and Ardila 1996), the effects of MDMA in
our sample could potentially be explained (or at least
aggravated) by this polydrug use. Nevertheless, correla-
tions between total MDMA use and use of other drugs
were low and not significant. Furthermore, within the
MDMA group, median split analyses indicated no inter-
actions of the degree of other drug use with the effects of
MDMA, except for a modulatory effect of the concom-
itant use of herbal ecstasy on RT switch costs in males.
Thus, with the exception of an isolated effect of herbal
ecstasy, within the MDMA group the use of other drugs
had no measurable impact, although it should be noted
that the power of these additional analyses was limited by
the small sample sizes.
It should be noted further that the present sample
consisted of first-year psychology students, which may
constrain external validity. Because of the relatively
young age of the participants and their presumed above
average level of intelligence, it is not clear how our
results generalize to the population at large. Previous
research has indicated that individuals with lower intel-
lectual abilities show greater decrements in cognitive
performance (Bolla et al. 1998). These authors posit that
individuals with higher intellect have a higher threshold
for developing cognitive problems after possible brain
injury. Following this line of reasoning, long-term effects
of MDMA use within the general population might result
in even more profound cognitive impairments than within
the present sample.
In conclusion, male recreational ecstasy users were
found to be impaired in the adaptive control capacities
involved in task switching and the WCST. They experi-
enced greater switch costs and increased perseverative
behavior compared to controls, which may well have
repercussions for daily life activities such as dealing with
traffic situations. Other executive functions, in particular
WM updating and response inhibition, were much less
subject to performance decrements. These new findings
were afforded by the use of a theoretical framework
proposed by Miyake et al. (2000) to systematically study
the efficiency of EFs. Adaptive control pertains not only
to those executive processes involved in adjusting be-
havior rapidly and flexibly in response to changes in
environmental demands, but also to those in performance
monitoring to signal the need to instigate such changes.
An important aspect of performance monitoring is the
ability to monitor on-going processing in the neurocog-
nitive system for signs of conflict or erroneous outcome.
Psychophysiological and neuroimaging studies conclude
that the anterior cingulate cortex is the central component
of the neural circuit for action monitoring. This dopami-
nergic control system is involved in detecting the activa-
tion of erroneous or conflicting responses (for reviews,
see Botvinick et al. 2001; Holroyd and Coles 2002).
Alcohol consumption has been found to impair this
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adaptive control function (Ridderinkhof et al. 2002a).
Considering the reported effects of MDMA consumption
on the DA system (O’Shea et al. 2001) and its effects on
adaptive control observed in the present study, future
research should aim also at addressing the effects of
MDMA on action monitoring.
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